Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/1999
05/14/1999CA2307220A1 Kits containing cyanoacrylate compositions comprising an antimicrobial agent
05/14/1999CA2307219A1 Prepolymer compositions comprising an antimicrobial agent
05/14/1999CA2307097A1 Compositions of lipid lowering agents
05/14/1999CA2306866A1 Methods and compositions for treating dermatoses
05/14/1999CA2305242A1 Extended release formulation
05/14/1999CA2302379A1 Sustained release ophthalmic compositions containing water soluble medicaments
05/14/1999CA2276436A1 Agglomerate of spherical polyvalent-metal alginate particulates, controlled-release preparation comprising difficultly soluble drug supported on said agglomerate, and processes for producing the both
05/14/1999CA2249952A1 Rapidly soluble solid in the oral cavity and process for producing the same
05/12/1999EP0914862A1 Novel adsorbent
05/12/1999EP0914832A1 Therapeutic material for periodontosis
05/12/1999EP0914827A1 Ophthalmic drug compositions
05/12/1999EP0914826A1 Wound healing accelerators
05/12/1999EP0914823A1 Sustained release preparation comprising tramadol and a preparation for its production
05/12/1999EP0914822A1 Rapid-release microdispersible ecadotril preparation
05/12/1999EP0914820A1 Plasters containing active agents
05/12/1999EP0914819A1 Kit for positioning a transdermal delivery system
05/12/1999EP0914818A1 Intraorally rapidly disintegrable tablet
05/12/1999EP0914214A1 Apparatus for coating foods or pharmaceuticals
05/12/1999EP0914202A1 Preservation by foam formation
05/12/1999EP0914168A1 New medicaments containing gelatin cross-linked with oxidized polysaccharides
05/12/1999EP0914161A2 Chitosan - related compositions and methods for delivery of nucleic acids into a cell
05/12/1999EP0914160A2 Hydrophobic carbomer complex compositions
05/12/1999EP0914143A1 Medicinal cyclosporin-a aerosol solution formulation
05/12/1999EP0914141A1 Stabilized antihepatitis-b vaccine tablets
05/12/1999EP0914139A2 Antiviral agents from plant extracts and use for treatment of viral infections
05/12/1999EP0914128A1 Formulation and method for treating congestive heart failure
05/12/1999EP0914127A2 Antifungal composition with enhanced bioavailability
05/12/1999EP0914119A2 Solid oral dosage forms of valsartan
05/12/1999EP0914113A1 Treating urinary incontinence using (s)-oxybutynin and (s)-desethyloxybutynin
05/12/1999EP0914106A1 Pharmaceutical products containing a complex of an amide-type local anesthetic and a polyacrylate
05/12/1999EP0914102A1 Compositions and methods for treating or preventing diseases of body passageways
05/12/1999EP0914101A2 Transdermal therapeutic systems
05/12/1999EP0914100A1 Oral composition comprising a triazole antifungal compound
05/12/1999EP0914099A1 Oral coated active drugs
05/12/1999EP0914098A1 Multi-layered osmotic device
05/12/1999EP0914097A2 Composition and dosage form comprising opioid antagonist
05/12/1999EP0914096A1 Microparticles and their use in wound therapy
05/12/1999EP0914095A1 Method for fabricating polymer-based controlled-release devices
05/12/1999EP0914094A1 Materials and methods for making improved liposome compositions
05/12/1999EP0914092A2 Microchip drug delivery devices
05/12/1999EP0914091A2 Ethene containing solutions and use thereof in methods of therapy or prophylaxis
05/12/1999EP0914070A1 Dental floss with increased loading weight
05/12/1999EP0914043A1 Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof
05/12/1999EP0810975B1 Method of producing hydrophilic or partially hydrophilic inorganic aerogels
05/12/1999EP0789559B1 Pharmaceutical composition containing a fusible carrier and method for producing the same
05/12/1999EP0755247A4 Hydrofluorocarbon propellant containing medicinal aerosols
05/12/1999EP0729382B1 Alkylglycoside-containing concentrate and uses thereof
05/12/1999EP0722313B1 Viscoelastic compositions of fluorinated organic compounds
05/12/1999EP0714283B1 Personal cleansing compositions
05/12/1999EP0636020B1 A pharmaceutical carrier system containing defined lipids
05/12/1999EP0525199B1 Composition containing ultrafine particles of magnetic metal oxide
05/12/1999EP0444081B1 Pharmaceutical preparation
05/12/1999CN1216472A A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent
05/12/1999CN1216471A Stabilized antihepatitis-B vaccine tablets
05/12/1999CN1216467A Immediate release PH-independent solid dosage form of cisapride
05/12/1999CN1216466A Polyol composition
05/12/1999CN1216465A Sustained release ionic conjugate
05/12/1999CN1216464A Powdery composition for nasal administration
05/12/1999CN1216253A Cancer curing medicine liquid
05/12/1999CN1216247A Plaster for drawing out pus and promoting tissue regeneration and its preparation
05/12/1999CN1043303C Ferric selenium injection for animal
05/11/1999US5902844 Solubilizing at least one water-soluble polymer and at least one amino acid-based containing component having a high molecular weight in an aqueous solvent to form a solubilized mixture; separating the aqueous solvent, spray drying
05/11/1999US5902790 Pharmaceutical angiostatic dipeptide compositions and method of use thereof
05/11/1999US5902789 Intranasally administering composition consisting of insulin, polysorbate-80, nonoxynol-9; reduced nasal irritation
05/11/1999US5902745 Cell encapsulation device
05/11/1999US5902632 Method of preparation of controlled release nifedipine formulations
05/11/1999US5902610 Formulations and methods of use of 2,2'-dithio-bis-ethane sulfonate
05/11/1999US5902607 Controlled release drug delivery; receptor site of lectin macromolecule reversibly binding to carbohydrate and activated in response to levels of free carbohydrate groups to effect ungelation and release of drug
05/11/1999US5902606 Solid and liquid solutions of sparingly water-soluble medicinal substances
05/11/1999US5902605 Delay delivery of drugs
05/11/1999US5902604 Submicron liposome suspensions obtained from preliposome lyophilizates
05/11/1999US5902603 Including a permeability enhancer absorbed therein; higher loads; high capacity and flux; crosslinked polyurethane reacted with water; administering steroids and olanzapine
05/11/1999US5902602 Estradiol-TTS having water-binding additives
05/11/1999US5902601 Volatile active substance containing plaster that may be produced without solvents
05/11/1999US5902598 Sustained release drug delivery devices
05/11/1999US5902594 Cyanoacrylate compositions comprising an antimicrobial agent
05/11/1999US5902593 Topically applied personal lubricant containing benzalkonium chloride as the active ingredient
05/11/1999US5902590 Cosmetic and/or pharmaceutical formulations
05/11/1999US5902577 Insulin-secreting cell lines, methods of production and use
05/11/1999US5902575 Method for treating the epithelium of bodily orifices with chlorine dioxide and a phosphate compound
05/11/1999US5902567 Administering to lung by inhalation physiologically acceptable salt to hydrate secretions, concurrently administering uridine triphosphate or derivative to stimulate secretion, collecting expectorated mucus sample
05/11/1999US5902565 Vaccine comprising immunogen adsorbed to an aluminum salt adjuvant, said vaccine preparation being a free flowing powder
05/11/1999US5902433 Process and a device for producing a transdermal therapeutic system for the administration of active substances to the skin in the form of a plane multichamber or multichamber-channel system
05/11/1999US5902225 Surfactants, post-foaming agents, compressed gas; for dispensing personal care cleaning compounds
05/11/1999CA2194610C Sustained-release formulation of animal growth hormone and process for preparation thereof
05/11/1999CA2160874C Nasal aromatic releasing compositions
05/11/1999CA2159580C Pharmaceutical compositions containing polyvinylpyrrolidone and a tri-ester and process of manufacture thereof
05/11/1999CA2155648C Condensed-phase microparticle composition and method
05/11/1999CA2151935C Oral compositions
05/11/1999CA2129652C Aids prophylactic lubricatng composition and devices for its use
05/11/1999CA2125148C A carbohydrate glass matrix for the sustained release of a therapeutic agent
05/11/1999CA2114014C Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
05/11/1999CA2098814C Method of producing microscopic particles made of hydrolytically decomposable polymers and containing active substances
05/11/1999CA2024953C Stabilized antibiotic compositions for animal feeding
05/10/1999CA2253112A1 Antihistamine sprays and ointments for relief of delayed contact dermatitis
05/07/1999CA2228977A1 Localized oligonucleotide therapy for preventing restenosis
05/07/1999CA2220621A1 Transdermal delivery system
05/07/1999CA2220562A1 Method and kit for positioning a transdermal delivery system
05/06/1999WO1999021908A1 Polymeric systems for drug delivery and uses thereof
05/06/1999WO1999021586A2 Complex between carrageenan and a water soluble drug having a specific granulometry and relative controlled release pharmaceutical compositions